AnGes Inc 4563.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 3:00 PM JST
365.00quote price arrow down-3.00 (-0.82%)
Volume
835,100
52 week range
285.00 - 1,060.00
Loading...
  • Open378.00
  • Day High378.00
  • Day Low365.00
  • Prev Close368.00
  • 52 Week High1,060.00
  • 52 Week High Date05/31/21
  • 52 Week Low285.00
  • 52 Week Low Date02/24/22

Key Stats

  • Market Cap436.99M
  • Shares Out153.07M
  • 10 Day Average Volume1.49M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-4.95

KEY STATS

  • Open378.00
  • Day High378.00
  • Day Low365.00
  • Prev Close368.00
  • 52 Week High1,060.00
  • 52 Week High Date05/31/21
  • 52 Week Low285.00
  • 52 Week Low Date02/24/22
  • Market Cap436.99M
  • Shares Out153.07M
  • 10 Day Average Volume1.49M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-4.95

RATIOS/PROFITABILITY

  • EPS (TTM)-88.20
  • P/E (TTM)-4.14
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On AnGes Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
AnGes, Inc., formerly AnGes MG, Inc., is a Japan-based company mainly engaged in the development of genetic medicines. The Company is involved in the development of hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, among others. As of December 31, 2012, the Company had four consolidated subsidiaries. On January 31, 2013, the Company sold a 95.3% stake of a Osaka-based subsidiary to...
Ei Yamada
President, Executive President, Chief Executive Officer, Chief Executive Officer of Subsidiaries, Representative Director
Address
7-7-15 Saito-asagi
Saito Bio-Incubator 4 Fl.
Ibaraki-shi, OSK
567-0085
Japan